Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geraldine Rauch

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
BMC Medical Research Methodology|November 26, 2020
Correction to: Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpointXieran Li, Carolin Herrmann, Geraldine Rauch
Journal of Biopharmaceutical Statistics|May 25, 2022
Two-stage designs with small sample sizesMeinhard Kieser, Geraldine Rauch, Maximilian Pilz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 31, 2019
[Research involving human subjects-principles and challenges for the work of ethics committees]Iris Pigeot, Ulrich Mansmann, Geraldine Rauch
Journal of Biopharmaceutical Statistics|December 31, 2010
A new outlier identification test for method comparison studies based on robust regressionGeraldine Rauch, Andrea Geistanger, Jürgen Timm
BMC Medical Research Methodology|February 7, 2020
Why do you need a biostatistician?Antonia Zapf, Geraldine Rauch, Meinhard Kieser
Statistical Methods in Medical Research|July 25, 2023
Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpointsDario Zocholl, Cornelia U Kunz, Geraldine Rauch
BMC Medical Research Methodology|January 6, 2018
A systematic comparison of recurrent event models for application to composite endpointsAnn-Kathrin Ozga, Meinhard Kieser, Geraldine Rauch
BMC Medical Research Methodology|March 28, 2024
Optimal futility stopping boundaries for binary endpointsMichaela Maria Freitag, Xieran Li, Geraldine Rauch
Methods of Information in Medicine|May 3, 2018
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?Geraldine Rauch, Werner Brannath, Matthias Brückner, et al.
Statistics in Medicine|October 9, 2018
What makes a biostatistician?Antonia Zapf, Marianne Huebner, Geraldine Rauch, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
BMC Medical Research Methodology|November 26, 2020
Correction to: Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpointXieran Li, Carolin Herrmann, Geraldine Rauch
Journal of Biopharmaceutical Statistics|May 25, 2022
Two-stage designs with small sample sizesMeinhard Kieser, Geraldine Rauch, Maximilian Pilz
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 31, 2019
[Research involving human subjects-principles and challenges for the work of ethics committees]Iris Pigeot, Ulrich Mansmann, Geraldine Rauch
Journal of Biopharmaceutical Statistics|December 31, 2010
A new outlier identification test for method comparison studies based on robust regressionGeraldine Rauch, Andrea Geistanger, Jürgen Timm
BMC Medical Research Methodology|February 7, 2020
Why do you need a biostatistician?Antonia Zapf, Geraldine Rauch, Meinhard Kieser
Statistical Methods in Medical Research|July 25, 2023
Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpointsDario Zocholl, Cornelia U Kunz, Geraldine Rauch
BMC Medical Research Methodology|January 6, 2018
A systematic comparison of recurrent event models for application to composite endpointsAnn-Kathrin Ozga, Meinhard Kieser, Geraldine Rauch
BMC Medical Research Methodology|March 28, 2024
Optimal futility stopping boundaries for binary endpointsMichaela Maria Freitag, Xieran Li, Geraldine Rauch
Methods of Information in Medicine|May 3, 2018
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?Geraldine Rauch, Werner Brannath, Matthias Brückner, et al.
Statistics in Medicine|October 9, 2018
What makes a biostatistician?Antonia Zapf, Marianne Huebner, Geraldine Rauch, et al.
Pageof 13